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Abstract: Patients with functional gastrointestinal tract who are unable to meet their nutritional
requirements may benefit from the use of enteral nutrition via feeding tubes which could be nasogastric,
percutaneous endoscopic gastrostomy and jejunostomy. Although enteral tube feeding has been
shown to promote nutritional status, improve wound healing, and enhance patients’ quality of life
(QoL), evidence of tube and feed complications and reduced QoL has also been reported. Despite
the increasing prevalence of patients on enteral tube feeding, no systematic review examining the
role of enteral tube feeding on patients’ QoL appears to have been published. Aim: The aim of
this systematic review is to evaluate the effect of enteral tube feeding on patients’ QoL. Method:
Three databases (EMBASE, Pubmed, and PsycINFO) plus Google Scholar were searched for relevant
articles based on the Population, Intervention, Comparator, Outcomes (PICO) framework. The
review was in line with preferred reporting items for systematic reviews and meta-analyses (PRISMA)
guidelines and involved the use of synonyms and medical subject headings. In addition, search terms
were combined using Boolean operators (AND/OR) and all the articles retrieved were exported to
EndNote for de-duplication. Results: Fourteen articles which met the criteria were included and
three distinct areas were identified: the effect of early versus late enteral tube feeding on QoL; the
QoL of patients on gastrostomy versus standard care, and the effect of enteral tube feeding on QoL.
Overall, nine studies reported improvement in the QoL of patients on enteral tube feeding, while
five studies demonstrated either no significant difference or reduction in QoL. Some factors which
may have influenced these outcomes are differences in types of gastrostomy tubes, enteral feeding
methods (including time patients spent connected to enteral feed/pump), and patients’ medical
conditions, as well as the generic and/or type of QoL measuring instrument used. Conclusion: Most
reviewed studies suggest that enteral tube feeding is effective in improving patients’ QoL. The use of
enteral tube feeding-specific QoL measuring instruments is recommended for future research, and
improved management strategies including use of mobile enteral feeding pumps should further
enhance patients’ QoL. More studies on the effect of delivery systems/enteral feeding pumps on QoL
are needed as research in this area is limited.
Keywords: enteral nutrition; enteral tube feeding; Quality of life; QoL; home enteral nutrition; enteral
feed; patients; systematic review
1. Introduction
There is evidence of increasing prevalence of patients on enteral tube feeding in the UK and
around the world [1,2] and this calls for greater scrutiny in terms of evaluating the impact of this
method of feeding on patients’ quality of life (QoL). In patients with neurological conditions such as
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stroke, swallowing problems and undernutrition are common and nutritional status can deteriorate in
various clinical settings and this has been linked to increased fatality and poor functional status [3–5].
Therefore, enteral tube feeding is an effective method of providing nutritional support to these patients
and other patients with functional guts who are unable to meet their nutritional requirements through
the oral route alone due to a range of conditions [6,7]. Therefore, patients with chronic conditions such
as stroke, multiple sclerosis, moto—neuron disease and dementia which may impact the patient’s
swallowing ability usually require enteral nutrition support to promote clinical outcomes [5,8]. Enteral
tube feeding may also be useful in patients with obstructive pathology of the oropharynx such as head
and neck cancer patients either as prophylactic measures or as post-radiotherapy interventions [9] due
to the effect of radiation on swallowing reflexes/muscle and radiation induced mucositis [10].
Sometimes, enteral tube feeding is needed to support patients with human immuno-deficiency
virus (HIV), those who fail to thrive and individuals with learning and intellectual disability and
may involve patients in their own homes, residential care, nursing homes, acute hospitals including
intensive care units [6,11,12]. There is evidence that enteral tube feeding can improve wound healing,
reduce length of hospital stay, prolong life and relatively save costs [11]. For instance, diabetes
specific enteral formula has been found to be effective in managing patients with diabetes on enteral
nutrition [13] while in patients with esophageal cancer, early enteral nutrition was effective in reducing
the incidence of postoperative pulmonary infection, enhancing early recovery and reducing length
of hospital stay and hospital cost [14]. Enteral tube feeding has also shown promising results in
the management of Crohn’s disease as it provided equal or higher remission rates than the current
medication in use [15]. However, despite the merits in the use of enteral tube feeding, challenges such
as its impact on patients’ QoL remain.
The nature of enteral feeding systems may be implicated in these problems. These include the
feed and enteral feeding tube which is usually placed or inserted in the patient [5]. Other enteral
feeding equipment and accessories including the feeding pump, the drip stand and syringes are
essential features of enteral nutrition provision which can bring challenges and potentially impact on
patients’ QoL.
QoL has been defined as the way in which illness, pain, reduced motor activity and unease may
influence daily behavior, social activities, psychological well–being and other aspects of an individual’s
life [16]. Therefore, when evaluating QoL, four dimensions are usually considered including motor
activity, functional, psychological and social dimensions [16]. In particular, QoL provides a measure
of general wellbeing, including both positive and negative features of life [17]. A range of QoL
measurement tools such as the EuroQoL-5-Dimensions (EQ-5D) which consists of questionnaires and
Visual Analogue Scale (VAS) [16,18,19], World Health Organization (WHO) [20], and the more specific
enteral nutrition NutriQoL [21] are now available. Govindaraju et al. [17] in their systematic review
of dietary patterns and QoL in older adults also selected articles employing a range of generic QoL
measuring tools. The authors noted that QoL is both subjective and objective constructs and measures
the subjective of health against the objective assessments of functioning and/or health status [17].
It remains unclear whether these QoL measuring instruments can identify the effect of the various
enteral feeding tubes such as nasogastric (NGT), nasojejunal (NJ), percutaneous endoscopic gastrostomy
(PEG), radiologically inserted gastrostomy (RIG) and percutaneous endoscopic jejunostomy (PEJ)
which require different procedures for placement in the respective anatomical sites on QoL [5,6,21]. In
addition, the care and management of these tubes are also different. The challenges of enteral tube
feeding such as tube blockage, kinking and leakage, stoma site infection, overgranulation of stoma site
and buried bumper syndrome may also have effect on patients’ QoL [22].
Other potential problems include the enteral feeding pump that delivers the feed and to which
patients could be connected for many hours [2,22]. In addition, continuous enteral feeding method can
restrict patients’ mobility and the noise from the pump can cause sleep disturbance [22]. However,
studies on patients and caregivers’ experiences of enteral feeding pumps and the impact on QoL
appear limited [23]. Patients on enteral tube feeding are sometimes unable to tolerate the feed and may
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suffer from bloating, diarrhea, constipation, nausea and vomiting [22,24]. Enteral tube feeding can also
have significant impact on body image [22]. In these circumstances, the patients’ QoL may be affected.
The approaches to enteral nutrition provisions in hospitals and in community settings may also
affect patients’ QoL as there are variations in the provision of enteral tube feeding in the UK and
globally [1,6]. For example, in the UK, there are established home enteral nutrition (HEN) teams in
some commissioning groups while there are none in others [1].
Given the role of enteral tube feeding in terms of its importance in prolonging life and reducing
length of hospital stay in patients with different health conditions and the range of challenges that
have been highlighted, it is not surprising that while some studies have noted the merits of enteral
nutrition provisions, other articles have drawn our attention to its demerits and the negative effects on
patients’ QoL. However, despite the studies conducted in this area, it would appear that there is no
systematic review that has attempted to explore the role of enteral tube feeding on patients’ QoL.
Aim: The aim of this systematic review is to evaluate the effect of enteral tube feeding on patients’ QoL.
Research question: Do enteral tube feeding provisions impact on patients’ QoL?
2. Method
This systematic review has been conducted in line with the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) [25].
2.1. Types of Studies
Due to the nature of the area being reviewed (enteral tube feeding and QoL), a range of study
designs including randomized controlled trials, cross-sectional studies, prospective cohort studies,
uncontrolled clinical trial and retrospective reviews were included in this review.
2.2. Participants and Interventions
Participants were patients on enteral tube feeding involving different enteral feeding tubes and
various types of enteral feed. The studies included evaluated the effect of various gastrostomy tube
placements, the timing of tube placement, HEN, and compared enteral feed and standard care on QoL.
2.3. Outcome Measures
The outcome of interest was the QoL of patients based on the use of different QoL measuring scales.
The tools used in the studies selected included the EuroQoL 5D (EQ5D) index and EQ5D VAS [26],
Short-Form 36 (SF-36) with social, physical, psychological and occupational domains of QoL [27],
European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaire
(QLQ-C30) and QLQ-OES19 (esophageal cancer specific); Inflammatory Bowel Disease Questionnaire
(IBDQ).
2.4. Search Terms and Search Strategy
The search strategy for this review was based on the Population, Intervention, Comparator,
Outcomes (PICO) framework (Table 1). The search terms are outlined in Table 1 and involved the use of
synonyms and medical subject headings (Mesh) and the combination of the search terms using Boolean
operators (AND/OR). Three databases (EMBASE, Pubmed and PsycINFO) plus Google Scholar were
searched for relevant articles (Figure 1). The reference list of articles was also searched for articles
of interest. The searches were conducted by one researcher (O.O.) and cross checked by three other
researchers (E.K., X.-H.W. and P.F.). All the articles retrieved from the databases were first exported to
EndNote (Analytics, Philadelphia, PA, USA) for de-duplication.
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Figure 1. Prisma flow chart. 
2.5. Inclusion and Exclusion Criteria 
Searches were conducted in the three databases from the date of inception to 27 December 2018. 
The following were the inclusion criteria: studies involving patients on only enteral tube feeding 
irrespective of the medical condition and type of enteral feeding tube; studies involving patients older 
than 18 years; studies involving patients’ QoL. 
The exclusion criteria were: studies involving patients on home parenteral nutrition; patients on 
both home parenteral and enteral tube feeding; patients on oral nutritional supplements; studies 
involving children aged below 18 years; studies involving family members and/or healthcare 
professionals; letters; studies comparing different feeding tubes; studies based only on medical 
conditions and gender of patients; studies with abstract only and insufficient information/data. 
2.6. Quality Assessment 
The quality of each study included in this review was evaluated by using the critical appraisal 
skills program (CASP) [28] tool. 
2.7. Data Extraction 
Data was extracted from the studies selected by one researcher (O.O.) and cross checked by three 
other researchers (E.K., X.-H.W. and P.F.) (Table 2). 
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Table 1. Search Terms and Search Strategy.
Patient/Population Intervention Comparator Outcomes of Interest Combining Search Terms
Patients on enteral tube feeding Enteral nutrition Control Quality of life
Patients on enteral tube feeding
OR Enteral feeding OR Enteral
nutrition OR Feeding, enteral
OR Nutrition, enteral
Nutrition, Enteral OR Enteral feeding OR Feeding,
Enteral OR Tube feeding OR Feeding, Tube OR Gastric
feeding tubes OR Feeding tube, Gastric OR Feeding
tubes, Gastric OR Gastric feeding tube OR Tube, Gastric
feeding OR Tubes, Gastric feeding
Control OR Standard
diet OR Normal diet
as tolerated OR
Baseline values
Life quality OR
Health-related quality of
life OR Health-related
quality of life OR
HRQoL OR QoL
Column 1 AND Column 2
AND Column 3
Table 2. Characteristics of the articles included in this review (N = 14).
Study
Reference
Country of
Study
Study
Type/Design Sample Size Age (Years) Aim/Objective
Interventions
Including Type
of Tube and/or
Enteral Feeding
Results of QoL Scores Following
Interventions Conclusion
The effect of early versus late enteral tube placement/feeding on QoL
Baker et al.
(2015) [26] Australia
Phase III
multicenter,
randomized
clinical trial
Intervention
N = 53
Standard care
N = 56
Total N = 109
Mean (SD)
Intervention:
61.8 (11.4)
Standard care:
63.7 (12.7)
Whether early
postoperative enteral
nutrition for
malnourished women
with advanced
epithelial ovarian
cancer can improve
their QoL compared
to Standard care
Nasojejunal
tube: Early
enteral feeding
versus Standard
care
Baseline EQ5D Index (SD)
Intervention = 0.70 (0.20)
Standard care = 0.65 (0.22)
6 weeks Postoperatively EQ5D
Index:
Intervention = 0.78 (0.22)
Standard care = 0.76 (0.15)
30 days Post-chemotherapy
EQ5D Index
Intervention = 0.85 (0.13)
Standard care = 0.78 (0.16)
Baseline VAS (SD)
Intervention = 60 (23)
Standard care = 51 (20)
6 weeks Postoperatively VAS
(SD)
Intervention = 69 (20)
Standard care = 61 (21)
30 days Post-chemotherapy VAS
Intervention = 72.8 (15.2)
Standard care = 65.2 (19.2)
Early enteral
feeding did not
significantly
improve patient’s
QoL compared to
standard care but
may improve
nutritional status
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Table 2. Cont.
Study
Reference
Country of
Study
Study
Type/Design Sample Size Age (Years) Aim/Objective
Interventions
Including Type
of Tube and/or
Enteral Feeding
Results of QoL Scores Following
Interventions Conclusion
Morton et al.
(2009)
[29]
New
Zealand
Retrospective
chart review
over a 24-month
period.
N = 36 Median = 52
To examine the
factors associated
with PEG insertion
and the effects of PEG
use on QoL and
functional outcomes
in head and neck
cancer (HNC)
patients receiving
chemoradiotherapy
PEG insertion:
(1) tube inserted
before treatment
or within 1
month of
commencement
of treatment
(2) tube inserted
1 month or more
after start of
treatment
Patients who still had PEG in situ
at the time of the survey had a
significantly worse total QoL score
(p = 0.006)
Overall QoL Score:
Nutrition mode at time of
study = 0.363 (p = 0.063)
PEG in situ at time of study = 0.518
(p = 0.006)
Longer PEG duration predicted
poor overall QoL (p < 0.01)
Early PEG
insertion and
shorter PEG
duration are
associated with
more favorable
QoL-related
outcomes
Quality of Life of patients on gastrostomy compared with standard care
Bannerman
et al. (2000)
[27]
United
Kingdom
Cross-sectional
and prospective
cohorts
Prospective
study: N = 54 Median = 58
To determine the
impact of
gastrostomy on QoL
Patients were
assessed prior to
gastrostomy
(endoscopic or
radiological)
placement at
baseline, 1, 6
and 12 months
No significant difference in SF-36
scores at the time of tube
placement and 1, 6, 12 months
follow-up (p > 0.05), except for
physical function score
(Mean ± SD)
Baseline scores = 43.8 (34.9)
6 months = 14.7 (20.9) p = 0.01.
No significant difference in the
proportion of patients showing
that gastronomy had a positive
impact on their QoL (p > 0.05).
Based on the PEG-Qu
assessment, at 6 and 12 months:
71% and 75% of patients
respectively expressed a positive
overall effect on their QoL
Most patients can
cope adequately
with the care of
gastrostomy,
despite
considerable
impairment of
physical function.
QoL of patients
fed via
gastrostomy is
independent of
nutritional
outcome.
Overall, the
positive impact of
gastrostomy on
QoL was
perceived in 55%
of patients and
80% carers
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Table 2. Cont.
Study
Reference
Country of
Study
Study
Type/Design Sample Size Age (Years) Aim/Objective
Interventions
Including Type
of Tube and/or
Enteral Feeding
Results of QoL Scores Following
Interventions Conclusion
Hossein
et al. (2011)
[30]
Iran Cross-sectionalstudy N = 100
Mean (SD)
59.73 ± 18.16
To assess the
perspectives of
patients regarding the
acceptability of PEG
tube placement and
evaluate the
outcomes
PEG tube
QoL index scores (Mean)
Pre-PEG: 19.25 ± 11.85
6 months after: 32.08 ± 27.74
When comparing the mean QoL
index scores before and after PEG
placement there was significant
improvement (p < 0.005) after PEG
placement
PEG tube is a
minimally
invasive
gastrostomy
method with low
morbidity and
mortality rates,
and is easy to
follow-up and to
replace when
blockage occurs
Kurien et al.
(2017)
[31]
United
Kingdom
Prospective
multicenter
cohort study
N = 100
(patients)
N = 100
(caregivers)
N = 200
(control)
Mean (SD)
Patients:
67 (14.7)
Caregivers:
65 (12.2)
Control:
60 (10.1)
To determine how
gastrostomies affect
QoL in patients and
caregivers
PEG (55%) +
RIG (45%)
Baseline (before gastrostomy)
versus 3 months post insertion
(Mean ± SD)
No significant longitudinal
changes in mean EuroQoL index
scores for patients (0.70 before vs.
0.710 after; p = 0.83) or caregivers
(0.95 before vs. 0.95 after; p = 0.32)
following gastrostomy insertion
QoL did not
significantly
improve after
gastrostomy
insertion for
patients or
caregivers.
Gastrostomies
may help
maintain QoL
Rogers et al.
(2007)
[32]
United
Kingdom
Cross-sectional
survey N = 243
Mean (SD)
65 (12)
To devise, pilot and
survey a PEG specific
questionnaire and
relate outcomes to
QoL
PEG
Global measures score (0–100)
QoL (Mean; SE) as measured by
UW-QoL
Never had PEG: 63 (1)
PEG removed at 7 months: 68 (3)
Still has PEG at 34 months: 41 (4)
Patients with
PEGs reported
significant deficits
in all UW-QOL
domains
compared to
non-PEG or
PEG-removed
patients and
reported a much
poorer QoL
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Table 2. Cont.
Study
Reference
Country of
Study
Study
Type/Design Sample Size Age (Years) Aim/Objective
Interventions
Including Type
of Tube and/or
Enteral Feeding
Results of QoL Scores Following
Interventions Conclusion
Salas et al.
(2009) [33] France
Randomized,
controlled study
N = 39
No systematic
gastrostomy
(standard
group) = 18
Systematic
gastrostomy
(experimental
group) = 21
Mean (SD)
Standard =
60.0 ± 4.5
Experimental =
58.7 ± 7.7
To assess the impact
of prophylactic
gastrostomy on the
6-month QoL, and to
determine the factors
related to this QoL
Systematic
percutaneous
gastrostomy
versus no
systematic
gastrostomy
QoL at Inclusion
SF36 Score
Standard: 49.4 ± 25.1
Experiment: 59.2 ± 21.8 (p = 0.19)
EORTC (QLQ-C30):
Standard: 57.8 ± 25.8 Experiment:
63.0 ± 24.1 (p = 0.37)
QoL at 6 months was significantly
higher in the group receiving
systematic prophylactic
gastrostomy (p = 10−3)
Prophylactic
gastrostomy
improves
post-treatment
QoL for
unresectable head
and HNC, after
adjusting for
other potential
predictive QoL
factors
The effect of Enteral tube feeding on QoL
Donohoe
et al. (2017)
[34]
Ireland Prospectivecohort study N = 149
Mean (SD)
62 ± 9
To analyze the impact
of supplemental HEN
post-esophageal
cancer surgery on
quality of life
HEN
QoL measured at baseline,
preoperatively, and at 1, 3, and 6
months
Mean Global QoL decreased
(p < 0.01) from 82 to 72.
Global QoL (follow-up long-term)
was not significantly different in
those with <10% vs. >10% weight
respectively (68.7 ± 20.6 vs.
70.95 ± 17.5, p = 0.519).
With persistent weight loss
(3–6 months postoperative, n = 12)
there was clinically relevant
decrease in QoL in physical
(76.7 vs. 87.5, p = 0.066) and social
function (76.4 vs. 87.8, p = 0.034)
Weight loss and
negative
consequences on
QoL occurs
despite
supplemental
enteral nutrition
in majority of
patients
Guo et al.
(2013)
[35]
China
Uncontrolled
pilot clinical
trial
N = 13 Mean (SD)26.1 (3.8)
To determine the
effect of exclusive
enteral nutrition
(EEN) on patients
QoL in adults with
active Crohn’s disease
Enteral nutrition
There were significant
improvements in total IBDQ scores
after 4-week EEN treatment
(Mean ± SD)
128.3 ± 15.8 to 182.9 ± 24.2
(p < 0.001)
A 4-week
treatment of EEN
improves QoL
significantly in
adults with active
Crohn’s disease
and was
acceptable by
most patients
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Table 2. Cont.
Study
Reference
Country of
Study
Study
Type/Design Sample Size Age (Years) Aim/Objective
Interventions
Including Type
of Tube and/or
Enteral Feeding
Results of QoL Scores Following
Interventions Conclusion
Loeser et al.
(2003)
[36]
Germany
Prospective
cross-sectional
(Study 1)
Prospective
longitudinal
(Study 2:
follow-up
4 months)
Cross-sectional
N = 155
Longitudinal
N = 56
Mean (SD)
64.3 ± 13.1
To assess QoL in
patients on HETF.
HETF
HETF/PEG
insertion
Study 1: When compared with
EORTC reference data, functional
scales were lower in HETF patients
and QoL was significantly lower in
non-competent patients.
Study 2: QLQ-C30 (N = 26)
PEG insertion: 44.2 ± 19.7
2 months: 46.5 ± 16.0
4 months: 50.6 ± 1
Lower QoL was observed in
non-competent than in competent
patients
QoL is decreased
in patients on
HETF. Part of this
explained by
malnutrition.
HETF can prevent
further weight
loss and improve
some aspects of
QoL
Roberge
et al. (2000)
[37]
France Prospectivestudy N = 39 Mean = 58
To evaluate the
impact of HETF on
QoL in patients
treated for head and
neck or esophageal
cancer.
Evaluations were
carried out 1st week
and 3rd week post
hospital discharge
HETF/PEG
insertion
QLQ-C30 Mean (SD)
Global health status: 45(19).
Overall, QoL slightly improved
3 weeks post-discharge; some
symptoms significantly improved
(p < 0.05): constipation, coughing,
social functioning and body
image/sexuality
Home enteral
tube feeding is a
physically well
accepted
technique
although some of
the patients may
experience
psychosocial
distress
Schneider
et al. (2000)
[38]
France Cross-sectionalstudy N = 38
Mean (SEM)
56 ± 5
To assess both the
QoL of long-term
patients on HEN (for
25 ± 5 months) and
the evolution of QoL
after initiation of
HEN
HEN vs.
general
population
EQ-5D index
HEN: 0.54 ± 0.07 vs.
General: 0.85 ± 0.0 (p < 0.05)
Visual Analogue Scale
HEN: 54.1 ± 4.2 vs.
General: 82.5 ± 0.3
(p < 0.05)
SF-36 (Mental Component Scale)
HEN: 46.2 ± 2.6 vs.
General: 51.8 ± 0.3
SF-36 (Physical Component Scale)
HEN: 37.1 ± 2.1 vs.
General: 46.5 ± 1.2
(p < 0.05)
QoL is poor in
HEN patients
compared to age
and sex matched
general
population. Most
patients describe
an improvement
in their QoL
following the
initiation of HEN
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Table 2. Cont.
Study
Reference
Country of
Study
Study
Type/Design Sample Size Age (Years) Aim/Objective
Interventions
Including Type
of Tube and/or
Enteral Feeding
Results of QoL Scores Following
Interventions Conclusion
Wu et al.
(2018)
[39]
China
Single-center,
prospective,
non-randomized
study
N = 142
Median (Range)
Minimally
invasive
esophagectomy/
laparoscopic
jejunal feeding
tube+HEN
(MIE): 62 (45–80)
Open
esophagectomy/
nasojejunal
feeding tube
(OE): 61 (43–80)
To investigate the
effect of 3 months
HEN on QoL and
nutritional status of
esophageal cancer
patients who were
preoperatively
malnourished.
MIE vs. OE
QoL (Global health status)
(Mean ± SD)
Preoperative
MIE:69.9 (9.1)
OE:70.1(10.3), p = 0.546
2 weeks
MIE: 19.6 (7.5)
OE: 18.4 (7.0), p = 0.821
3 months
MIE: 55.7 (7.4)
OE: 41.8 (7.0), p = 0.001
MIE and
subsequent
treatment with 3
months HEN can
improve QoL and
reduce the risk of
malnutrition in
preoperatively
malnourished
patients
Zeng et al.
(2017)
[40]
China Non-RandomizedClinical trial
N = 60
HEN: N = 30
Control
(Standard Care):
N = 30
Mean (SD)
HEN: 61.7 ± 8.4
Control:
59.3 ± 10.4
To characterize the
effect of HEN on
nutritional status and
QoL of esophageal
cancer patients who
underwent Ivor
Lewis esophagectomy
for cancer
HEN vs.
standard care
Combined use of QLQ-C30 and
QLQ-ES18
Compared to the control group,
the HEN group achieved higher
Global QoL scores, and most of
their functional index scores were
better. However, 24 weeks after
surgery, QoL indexes did not differ
significantly between the two
groups
HEN can reduce
the incidence of
malnutrition or
latent
malnutrition and
help restore QoL
in the patients
with esophageal
cancer in the early
period (24 weeks)
after surgery
Abbreviations: EEN (Exclusive Enteral Nutrition); EQ5D Index (EuroQoL 5D) and EQ5D Visual Analogue Scale (VAS); SF-36 (Short-form 36); PEG (Percutaneous Endoscopic gastrostomy);
PEG Qu (10 questions, specific about gastrostomy tube and QoL); EORTC (European Organization for Research and Treatment of Cancer) quality of life questionnaire (QLQ-C30) and
QLQ-OES19 (esophageal cancer specific); HEN (Home Enteral Nutrition); HETF (Home Enteral Tube Feeding); HNC (Head and Neck Cancer); IBDQ (Inflammatory Bowel Disease
Questionnaire); MIE (Minimally Invasive Esophagectomy); OE (Open Esophagectomy); PG-SGA (Patient Generated Subjective Global Assessment); QoL (Quality of Life); QLQ-ES18
(Esophageal module 18 questionnaire); RIG (Radiologically Inserted Gastrostomy); SD (Standard Deviation); SEM (Standard Error of Mean); UW-QoL (University of Washington Quality of
Life questionnaire).
Nutrients 2019, 11, 1046 11 of 16
3. Results
Three studies each were conducted in the United Kingdom, France and China. Furthermore,
Ireland, Australia, Iran, Germany and New Zealand each had one study (Table 2). These studies were a
mix of randomized controlled trials [26,33], prospective cohort studies [27,31,34,37], non-randomized
studies [39,40], cross-sectional studies [30,32,38], retrospective review [29], cross-sectional and
longitudinal studies [36] and uncontrolled clinical pilot study [35].
Based on the objectives, the interventions and outcomes of the studies, the following three areas
were identified from the review;
• The effect of early versus late enteral tube placement/feeding on QoL
• QoL of patients on gastrostomy compared with standard care
• The effect of enteral tube feeding on QoL
3.1. The Effect of Early Versus Late Enteral Tube Placement/Feeding on QoL
Two studies [26,29] evaluated the effect of early versus late enteral tube placement/feeding or
standard care on QoL. Baker et al. [26] found that early enteral feeding (intraoperative nasojejunal tube
placement) for malnourished women with advanced epithelial ovarian cancer did not significantly
improve patient’s QoL 6 weeks postoperatively compared to standard care, but may improve nutritional
status. This study was based on the use of nasojejunal tube and EQ5D Index tool and VAS. On the
other hand, Morton et al. [29] noted that early PEG insertion and shorter PEG duration are associated
with more favorable QoL-related outcomes based on the University of Washington Head and Neck
Disease-Specific Measure (UW-QoL).
3.2. Quality of Life of Patients on Gastrostomy Compared with Standard Care
Five studies [27,30–33] explored the effect of different gastrostomies on QoL. Kurien et al. [31]
observed no significant longitudinal changes in mean EuroQoL index scores for patients (0.70 before
vs. 0.710 3 months after; p = 0.83) following gastrostomy insertion. In fact, Rogers et al. (2007) reported
that patients with PEGs (at 34 months) reported significant deficits in all UW-QoL domains compared
to non-PEG or PEG-removed (at 7 months) patients and reported a much poorer QoL.
Bannerman et al. [27] found no significant difference (p > 0.05) in SF-36 scores at the time of
tube placement and 1, 6, 12 months follow-up, except for physical function score. However, the
PEG-Qu assessment showed at 6 and 12 months, 71% and 75% of patients respectively expressed
a positive overall effect of gastrostomy on their QoL. In addition, Hossein et al. [30] demonstrated
significant improvement (p < 0.005) 6 months after PEG placement in the QoL index scores. There is
also evidence that prophylactic gastrostomy can improve post-treatment QoL for unresectable head
and neck cancer patients, after adjusting for other potential predictive QoL factors [33] based on the
SF36 and QLQ-C30 scores.
3.3. The Effect of Enteral Tube Feeding on Quality of Life
Seven studies [34–40] assessed the effect of enteral tube feeding on QoL. Based on the QLQ-C30
and QLQ-OES19 tools, Donohue et al. [34] found that weight loss and negative consequences on QoL
occurred in most post-esophageal cancer surgery patients, despite supplemental HEN for further
4 weeks. These findings were similar to that of Loeser et al. [36] who noted that QoL is reduced in
patients on home enteral tube feeding (HETF), although HETF can prevent further weight loss and
improve some aspects of QoL within 4 months. This study relied on the QLQ-C30 tool.
Schneider et al. [38] reported that although QoL is poor in patients on HEN (for 25 months)
compared to age and sex matched general population, most patients described an improvement
in their QoL following the initiation of HEN using the SF36 tool, EQ5D Index and VAS. Similarly,
Roberge et al. [37] found that in patients treated for head and neck or esophageal cancer on HETF,
overall, QoL slightly improved 3 weeks post-discharge, based on the QLQ-C30 scale. Furthermore,
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Wu et al. [39] observed that minimally invasive esophagectomy and subsequent treatment with 3 months
HEN can improve the QoL and reduce the risk of malnutrition in preoperatively malnourished patients
based on the QLQ-C30 and PG-SGA. In the Zeng et al. [40] study, the authors used the combined
QLQ-C30 and QLQ-ES18 to demonstrate that compared to the control group, the HEN group achieved
higher Global QoL scores, and most of their functional index scores were better, at 4 and 12 weeks
after surgery. However, 24 weeks after surgery, QoL indexes did not differ significantly between
the two groups. A 4-week treatment based on exclusive enteral nutrition (EEN) also improved QoL
significantly in adults with active Crohn’s disease using the IBDQ [35].
4. Discussion
Evaluation of the selected studies on the impact of enteral tube feeding on QoL resulted in
the emergence of 3 distinct areas (the effect of early versus late enteral tube feeding; the QoL of
patients on gastrostomy versus standard care, and the effect of enteral tube feeding on QoL) with
different outcomes observed in each area. Overall, nine [27,29,30,33,35,37–40] of the 14 studies
included showed improvement in the QoL of patients on enteral tube feeding, while the remaining five
studies [26,31,32,34,36] demonstrated either no significant difference or reductions in QoL (Table 2).
Gastrostomies resulted in improved QoL compared to standard care in the majority of studies across a
variety of patient conditions over a 6–12 month post gastrostomy timeframe [27,30,33], although in the
other studies [31,32], there was either no significant change or a decrease in QoL over 3–34 months post
gastrostomy tube placement. Similarly, in the majority of studies, enteral tube feeding /HEN showed a
positive effect on QoL in a range of patient conditions, over a 3 week–25 month timeframe [35,37–40],
while in the other studies [34,36], enteral tube feeding /HEN showed a reduction in QoL over a 4 to
6 month period.
The differences observed in the outcomes of the studies across the three areas outlined above
could be due to a range of factors. These possible factors and the implications for research and practice
will be discussed.
4.1. Factors Influencing the Role of Enteral Tube Feeding on Patients’ QoL
These factors may include the types of gastrostomy feeding tubes, the various chronic conditions
requiring enteral tube feeding, the enteral feeding methods, the time spent by patients being connected
to enteral feed/pump and the different clinical settings [2,22,27,38]. Furthermore, the use of generic
QoL measurement tools is another factor which may influence the outcome of studies on the role of
enteral tube feeding on QoL. In this review, different QoL measurement tools were used including the
EQ5D with the EQ5D VAS [26,31], the SF-36 and the PEG Qu which has 10 questions, specific about
gastrostomy tube and QoL [27]. The vast array of generic QoL measurement tools used in the studies
selected were developed and validated by different researchers and in different population group,
which may partly explain the differences in the outcomes of the studies [21]. Govindaraju et al. [17]
in a previous review noted that it is possible for two individuals with identical health status to have
different QoL based on their expectation and their capacity in health or illness, socio-economic status,
age and social support.
There were a range of enteral feeding tubes such as NGT, NJ, PEG and RIG, used by the patients
in the selected studies. These gastrostomy tubes vary in their indications, method of tube placement,
anatomical sites, complications, and care and management [41–43]. Therefore, the impact of the
different gastrostomy tubes on QoL will be different.
Similarly, the pathophysiology of the long-term conditions requiring enteral tube feeding such as
stroke, Crohn’s disease and cancers are different [43,44], and the differing treatment options may also
have implications for patients’ QoL. The settings where the studies included took place varied from
the community such as HEN to acute hospitals [2,43,45] and these different settings may also influence
the impact of enteral tube feeding on patients’ QoL. Methods of enteral feeding could be in the form of
bolus, gravity and the use of stationary or mobile enteral feeding pumps and each of these enteral
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feeding methods have their advantages and drawbacks in terms of how they impact patients’ QoL [46].
For example, the long hours spent by patients who are connected to enteral feed/pump may affect
family life, social activities and QoL [47] and the use of mobile pumps and carry bags are possible
strategies for ameliorating these challenges.
The differences observed with respect to the impact of enteral tube feeding on QoL is underscored
by the fact that although this method of feeding has significant advantages, it is not perfect [48].
There is evidence that this feed delivery route is efficacious, lowers costs and safety compared with
parenteral nutrition [6]. However, there are also physical complications, poor psychological outcomes
such as depression associated with patients on enteral tube feeding [6]. Fears of being dependent
and institutionalized, and the inability to perform activities of daily living are some of the challenges
of enteral tube feeding which may impact patients’ QoL [6]. Other potential problems associated
with enteral tube feeding are interference with family life, intimate relationships, social activities and
hobbies [32]. Despite the difficulties of enteral tube feeding highlighted above, gastrostomy tube
placement is based on the understanding that enteral tube feeding provides more clinical benefits,
patient comfort, functional status and QoL when compared to malnutrition [6].
4.2. Implications for Research and Practice
It would appear that some of the studies included in this review recognized the limitations of
using generic QoL measurement tools for evaluating patients on enteral tube feeding by including
PEG specific questionnaires to complement these tools. For example, Rogers et al. [32] used the
UW—QoL and PEG questionnaire for their study. In addition, the SF-36 and the PEG Qu which
has 10 questions, specifically about gastrostomy tube and QoL were used by Bannerman et al. [27]
to explore QoL in patients on enteral tube feeding. Cuerda et al. [21] went further to develop and
validate a specific questionnaire (NutriQoL) to assess health-related QoL in patients on HEN. One
of the justifications for their study was that several studies on patients receiving HEN used generic
measurement instruments to assess patients’ QoL. The authors noted that these generic tools were
not sensitive enough in identifying the effect of enteral tube feeding on patients’ QoL. Based on the
process used in developing and validating the NutriQoL questionnaire, it was concluded that this
measurement tool is valid, reliable and useful instrument for assessing the QoL of patients on HEN
irrespective of the disease and/or the route of administration [46,49].
Strategies for ameliorating some of the challenges of enteral tube feeding and improving patients’
QoL should be promoted. These approaches could involve the development of technology such as
improved mobile enteral feeding pump with less noise, development of HEN services in the community
to provide specialist enteral nutrition services and support patients to reduce the risk of feed, tube and
pump complications and thus improve their QoL.
5. Limitations of the Review
The use of generic QoL tools/questionnaires to evaluate the impact of enteral tube feeding on
patients’ QoL presents a significant limitation. However, this has been discussed extensively in
this review to raise awareness among researchers and recommendations for future research have
been suggested.
6. Conclusions
Most studies in this review suggest that enteral tube feeding is effective in improving patients’
QoL. The varying outcomes of the effect of enteral tube feeding on QoL across the three areas may be
partly explained by differences in types of gastrostomy tubes, enteral feeding methods (including time
patients spent connected to enteral feed/pump), and patients’ medical conditions, as well as the type of
QoL measuring instrument used.
However, the use of an enteral nutrition specific QoL measuring tool which does not discriminate in
terms of the type of enteral feeding tube and patients’ condition and has been validated is recommended
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for evaluating the impact of enteral tube feeding on patients’ QoL. In addition, improved management
strategies including the use of mobile enteral feeding pumps should further enhance patients’ QoL.
More studies on the effect of delivery systems/enteral feeding pumps on QoL are needed as research in
this area is limited.
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